Applied Therapeutics Inc
NASDAQ:APLT
Income Statement
Earnings Waterfall
Applied Therapeutics Inc
Income Statement
Applied Therapeutics Inc
| Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
11
N/A
|
11
N/A
|
11
N/A
|
10
-6%
|
10
+2%
|
10
+1%
|
10
+1%
|
0
-96%
|
0
-42%
|
0
-54%
|
1
+720%
|
|
| Operating Income | |||||||||||||||||||||||||||
| Operating Expenses |
(17)
|
(28)
|
(46)
|
(49)
|
(69)
|
(88)
|
(94)
|
(106)
|
(104)
|
(102)
|
(106)
|
(105)
|
(100)
|
(91)
|
(83)
|
(81)
|
(77)
|
(73)
|
(75)
|
(128)
|
(132)
|
(147)
|
(105)
|
(110)
|
(112)
|
(99)
|
|
| Selling, General & Administrative |
(6)
|
(9)
|
(13)
|
(17)
|
(20)
|
(27)
|
(33)
|
(37)
|
(41)
|
(42)
|
(43)
|
(41)
|
(36)
|
(32)
|
(27)
|
(25)
|
(24)
|
(22)
|
(21)
|
(40)
|
(45)
|
(56)
|
(56)
|
(65)
|
(67)
|
(60)
|
|
| Research & Development |
(11)
|
(19)
|
(32)
|
(33)
|
(49)
|
(62)
|
(62)
|
(69)
|
(63)
|
(61)
|
(63)
|
(63)
|
(64)
|
(59)
|
(56)
|
(57)
|
(53)
|
(51)
|
(54)
|
(89)
|
(87)
|
(91)
|
(49)
|
(44)
|
(44)
|
(39)
|
|
| Operating Income |
(17)
N/A
|
(28)
-63%
|
(46)
-63%
|
(49)
-8%
|
(69)
-40%
|
(88)
-28%
|
(94)
-7%
|
(106)
-12%
|
(104)
+2%
|
(102)
+1%
|
(106)
-3%
|
(105)
+1%
|
(100)
+4%
|
(91)
+9%
|
(83)
+9%
|
(71)
+15%
|
(66)
+6%
|
(63)
+6%
|
(65)
-3%
|
(118)
-83%
|
(121)
-2%
|
(136)
-12%
|
(104)
+23%
|
(109)
-4%
|
(112)
-3%
|
(98)
+12%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
3
|
4
|
4
|
4
|
3
|
2
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(5)
|
(5)
|
(0)
|
0
|
(8)
|
(35)
|
(57)
|
(160)
|
(124)
|
(137)
|
(5)
|
62
|
41
|
78
|
|
| Pre-Tax Income |
(17)
N/A
|
(28)
-62%
|
(46)
-63%
|
(49)
-8%
|
(69)
-40%
|
(88)
-28%
|
(94)
-7%
|
(106)
-13%
|
(104)
+2%
|
(102)
+1%
|
(106)
-3%
|
(105)
+1%
|
(105)
0%
|
(95)
+9%
|
(83)
+13%
|
(70)
+16%
|
(73)
-5%
|
(97)
-32%
|
(120)
-24%
|
(276)
-130%
|
(243)
+12%
|
(270)
-11%
|
(106)
+61%
|
(44)
+58%
|
(68)
-55%
|
(18)
+73%
|
|
| Net Income | |||||||||||||||||||||||||||
| Income from Continuing Operations |
(17)
|
(28)
|
(46)
|
(49)
|
(69)
|
(88)
|
(94)
|
(106)
|
(104)
|
(102)
|
(106)
|
(105)
|
(105)
|
(95)
|
(83)
|
(70)
|
(73)
|
(97)
|
(120)
|
(276)
|
(243)
|
(270)
|
(106)
|
(44)
|
(68)
|
(18)
|
|
| Net Income (Common) |
(17)
N/A
|
(28)
-62%
|
(46)
-63%
|
(49)
-8%
|
(69)
-40%
|
(88)
-28%
|
(94)
-7%
|
(106)
-13%
|
(104)
+2%
|
(102)
+1%
|
(106)
-3%
|
(105)
+1%
|
(105)
0%
|
(95)
+9%
|
(83)
+13%
|
(70)
+16%
|
(73)
-5%
|
(97)
-32%
|
(120)
-24%
|
(276)
-130%
|
(243)
+12%
|
(270)
-11%
|
(106)
+61%
|
(44)
+58%
|
(68)
-55%
|
(18)
+73%
|
|
| EPS (Diluted) |
-1.23
N/A
|
-1.63
-33%
|
-3.55
-118%
|
-2.35
+34%
|
-3.11
-32%
|
-3.91
-26%
|
-4.28
-9%
|
-4.38
-2%
|
-3.97
+9%
|
-3.9
+2%
|
-4.12
-6%
|
-3.98
+3%
|
-3.88
+3%
|
-1.98
+49%
|
-2.18
-10%
|
-1.23
+44%
|
-0.92
+25%
|
-1.06
-15%
|
-1.42
-34%
|
-2.19
-54%
|
-1.59
+27%
|
-1.87
-18%
|
-0.76
+59%
|
-0.31
+59%
|
-0.47
-52%
|
-0.12
+74%
|
|